HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN

Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.

NEWS

November 16, 2020

Atropos is one of the companies selected for Nature Biotechnology’s

new article on senolytics. Read more >>

August 13, 2020

We are excited to collaborate with The Estée Lauder Companies

in a joint development agreement to discover senomodulators!  >>

AEnB2UrguPSQljdC_wqOEs_5dlBW3TRZ0Vr-HllA

Atropos, the Fate whose duty it was to cut the threads of life.

 

Robert S. Holzman, MD

The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998

©2018 by Atropos Therapeutics Inc.. Proudly created with Wix.com